Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.10.20.683049

Benchmarking resting state fMRI connectivity pipelines for classification: Robust accuracy despite processing variability in cross-site eye state prediction

Abstract

The rapid evolution of machine learning (ML) methods has yielded promising results in human brain neuroscience. However, the reproducibility of ML applications in neuroimaging remains limited, challenging the generalizability of inferences to broader populations. In addition to the inherent variability of the brain activity (both in healthy and pathological states), poor reproducibility is further enhanced by inconsistencies in data preprocessing techniques and methods for calculating functional connectivity (FC), which are used as parameters for brain state classification. To systematically assess the impact of abovementioned factors on ML applications to fMRI data, we benchmarked a comprehensive set of FC analysis pipelines for the classification task between fMRI data recorded in two fundamentally different states: eyes open and eyes closed. In contrast to studies involving heterogeneous clinical populations or using complex cognitive tasks, our controlled experimental design - based on two independent datasets of healthy participants collected in different laboratories - minimizes variability related to a task design or pathological brain states. Classification accuracy and reproducibility were compared for 256 distinct FC analysis pipelines, covering common preprocessing approaches, brain parcellation schemes, and connectivity metrics. Notably, we employed two ways of validation: a direct cross-site validation strategy - when a model was trained on one site and tested on another, and few-shot domain adaptation - when a few samples of testing site were added to the train set. Despite the substantial variability in pipeline configurations, we observed consistently high classification accuracy ([~]80%), confirming that FC-based models can robustly discriminate between well-defined brain states (eye conditions) across different acquisition sites. Best results both in terms of classification accuracy and stability were observed using Pearson correlation and tangent space parametrization as FC, Brainnetome as atlas, and confound regression strategies based on the CompCor method. These findings highlight the resilience of rs-fMRI FC-derived characteristics to methodological variation and support their utility in the discovery of biomarkers, particularly in settings that involve stable and reproducible brain states.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Medvedeva, T., Knyazeva, I., Masharipov, R., Korotkov, A., Cherednichenko, D., Kireev, M.. 2025-10-21. Benchmarking resting state fMRI connectivity pipelines for classification: Robust accuracy despite processing variability in cross-site eye state prediction. https://doi.org/10.1101/2025.10.20.683049

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗